Picton Mahoney Asset Management purchased a new stake in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 75,000 shares of the company's stock, valued at approximately $767,000. Picton Mahoney Asset Management owned 0.33% of Oaktree Acquisition Corp. III Life Sciences as of its most recent SEC filing.
A number of other large investors have also recently modified their holdings of OACC. K2 Principal Fund L.P. purchased a new stake in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at $1,945,000. Sculptor Capital LP bought a new position in Oaktree Acquisition Corp. III Life Sciences in the fourth quarter worth about $2,490,000. TENOR CAPITAL MANAGEMENT Co. L.P. bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the fourth quarter valued at approximately $2,988,000. Lighthouse Investment Partners LLC bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at $3,039,000. Finally, Two Sigma Investments LP bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the 4th quarter worth about $4,358,000.
Oaktree Acquisition Corp. III Life Sciences Price Performance
Oaktree Acquisition Corp. III Life Sciences stock remained flat at $10.47 during mid-day trading on Monday. The company's stock had a trading volume of 1,811 shares, compared to its average volume of 18,635. Oaktree Acquisition Corp. III Life Sciences has a twelve month low of $9.95 and a twelve month high of $10.85. The business has a 50 day simple moving average of $10.48.
Oaktree Acquisition Corp. III Life Sciences Company Profile
(
Free Report)
Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.
Featured Stories
Before you consider Oaktree Acquisition Corp. III Life Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oaktree Acquisition Corp. III Life Sciences wasn't on the list.
While Oaktree Acquisition Corp. III Life Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access